StockData
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc. (STRO) income statement

STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$8.50−0.42 (-4.71%)

Close on Nov 18, 2026Market cap $140.94MP/E –Yield –

See a number that looks wrong?